CORMORANT ASSET MANAGEMENT, LP purchased 1.9% of their position (1M shares) of AMBRX BIOPHARMA CAYMAN, INC. on the open market
Open‑market purchase worth $10.21M — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 3/16/2023ACC: 0000929638-23-000867
10% Owner
Since Mar 2023
+1M
Net shares
Net buyer
$10.21M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
1M acquired
Non-Derivative Transactions3
Ordinary Shares
Indirect
Shares
+250K
Price / share
$9.95
Trade value
$2.49M
% of position
0.5%
3/14/2023
52.50M→52.75M
Ordinary Shares
Indirect
Shares
+250K
Price / share
$10.60
Trade value
$2.65M
% of position
0.5%
3/15/2023
52.75M→53M
Ordinary Shares
Indirect
Shares
+500K
Price / share
$10.15
Trade value
$5.07M
% of position
0.9%
3/16/2023
53M→53.50M
Total
Net shares
+1M
Net value
$10.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 3/14/2023 | P · Purchase | +250K | $9.95 | $2.49M | 0.5% | 52.50M | 52.75M |
| Ordinary Shares Indirect | 3/15/2023 | P · Purchase | +250K | $10.60 | $2.65M | 0.5% | 52.75M | 53M |
| Ordinary Shares Indirect | 3/16/2023 | P · Purchase | +500K | $10.15 | $5.07M | 0.9% | 53M | 53.50M |
| Total | +1M | $10.21M | ||||||
Derivative Transactions0
No derivative transactions reported